Light on the horizon for Swedish biopharma

The industry is moving forward! In an interview with SwedenBIO, the British magazine Mednous highlights in its latest issue the eventful life science autumn in Sweden. The journal mentions several members who have advanced their research. These include Hansa Medical's positive phase two data and the interest in Immunicum's early cancer studies in the newfound collaboration with Merck and Pfizer.